About Lucy Coassin
Lucy Coassin is a chief executive officer, interim and director at Hawthorne Health.
Form D filings also name Lucy Coassin as a director at SimBioSys.
Experience
This experience comes from Lucy Coassin's profile and from SEC filings. For roles taken from filings, the years are when the filings name Lucy Coassin in the role, so the role may have started earlier or lasted longer.
Hawthorne Health, Inc. Current
Chief Executive Officer, Interim and director
2023 – Present · Roseville, CA
Provides clinical trial services for sponsors through community sites and home visits.
NV
Northpond Ventures Current
Director
2023 – Present
II
Inflammatix, Inc. Current
Director Board of Directors
2023 – Present
OC
Octave Current
Director Board of Directors
2023 – Present
CH
Current Health
Head of Pharma
2021 – 2023
S3
Science 37
Director Of Business Development
2020 – 2021
FB
Farcast Biosciences
Director Biopharma Business Development
2017 – 2019
GE
Genentech
Business Development MBA Intern
2015
LT
Life Technologies
Sr. Account Manager
2008 – 2014
Key Colleagues at Startups
The people Lucy Coassin works with at each company, as listed on that company's latest Form D.
Hawthorne Health, Inc. · Form D, Aug 13, 2026
JR
Joshua Rose
Former Chief Executive Officer, Hawthorne Health and director
Jodi Akin
Founder, Hawthorne Health and director
AC
Antonio Clapsis
Director
Richard Daly
Chairman, VieCure; Former CEO, DNAnexus
Andrea Jackson
Partner, Northpond Ventures and director
JD
Jonathan DiVincenzo
President and Chief Operating Officer, Bio-Rad Laboratories, director
MM
Maddie Maloney
Resigned As Director On 02/18/2026
SimBioSys, Inc. · Form D, Jan 6, 2025
VC
Vikram Chaudhery
Director
RA
Ronnie Andrews
Director
WH
William Hyun
Director
JP
Joseph Peterson
Executive officer and director
SS
Stacey Stevens
Chief Executive Officer and director